Intervention

DPP4

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

Comparison of Type 2 Diabetes Pharmacotherapy RegimensNCT05073692 · 2021-07-01

BESTMED: Observational Evaluation of Second Line Therapy Medications in DiabetesNCT05161429 · 2021-07-01

Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β CellNCT03180281 · 2017-07-01

Common conditions

Type 2 Diabetes Mellitus2 Cardiovascular Diseases1 Diabetes Mellitus, Type 21

Leading sponsors

Brigham and Women's Hospital1 First Affiliated Hospital Xi'an Jiaotong University1 Kaiser Permanente1

Trial status mix

UNKNOWN2

COMPLETED1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.